^
HIF1A overexpression
HER2 Negative Breast Cancer
albumin-bound paclitaxel
Sensitive
:
B
ESMO-BC 2021 - 1wk
BACH1 overexpression
HER2 Negative Breast Cancer
albumin-bound paclitaxel
Sensitive
:
B
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A1
ESMO-BC 2021 - 1wk
PIK3CA mutation + HR positive
HER2 Negative Breast Cancer
alpelisib
Sensitive
:
A1
The Oncologist - 1wk
HR positive
HER2 Negative Breast Cancer
abemaciclib
Sensitive
:
A1
ESMO-BC 2021 - 1wk
HER-2 negative
HER2 Negative Breast Cancer
bevacizumab
Sensitive
:
A2
ESMO-BC 2021 - 1wk
ER positive
HER2 Negative Breast Cancer
palbociclib
Sensitive
:
B
ESMO-BC 2021 - 1wk
ER positive
HER2 Negative Breast Cancer
letrozole
Sensitive
:
C2
ESMO-BC 2021 - 1wk
ER positive
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
C2
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
eribulin mesylate
Sensitive
:
C2
ESMO-BC 2021 - 1wk
ER positive + PGR positive
HER2 Negative Breast Cancer
tamoxifen
Sensitive
:
C3
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
palbociclib
Sensitive
:
A1
Cancer Invest - 2wk
HER-2 negative
HER2 Negative Breast Cancer
eribulin mesylate
Sensitive
:
A2
Int J Clin Oncol - 2wk
HR positive
HER2 Negative Breast Cancer
everolimus
Sensitive
:
A1
BRCA2 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
A1
BRCA1 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
A1
BRCA1 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A1
BRCA2 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A1
HER-2 negative
HER2 Negative Breast Cancer
CaT
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
docetaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
paclitaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
albumin-bound paclitaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
ixabepilone
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
capecitabine
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
gemcitabine
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
vinorelbine tartrate
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
toremifene
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
letrozole
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
anastrozole
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
carboplatin + docetaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
tamoxifen
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
carboplatin + albumin-bound paclitaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
everolimus
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
TC
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our